Genmab (GMAB)
(Delayed Data from NSDQ)
$23.53 USD
-0.18 (-0.76%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $23.52 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: AMC |
9/2024 | $0.31 | 0.00% |
Earnings Summary
For their last quarter, Genmab (GMAB) reported earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.29 per share. This reflects a negative earnings surprise of 24.14%. Look out for GMAB's next earnings release on November 06, 2024. For the next earning release, we expect the company to report earnings of $0.31 per share, reflecting a year-over-year decrease of 34.04%.
Earnings History
Price & Consensus
Zacks News for GMAB
Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround
GMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services